Journals / Journal of Experimental and Clinical Medicine / 2020 / Cilt: 37 - Sayı: 1

The long term renal and bladder function outcomes of patients with posterior urethral valve

Pages
11–16
Publication Date
2020-03-23
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Life long follow-up is obligate to protect from renal failure.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:We aimed to evaluate the preoperative and postoperative renal and bladder functions of patients operated for posterior urethral valve (PUV).
📊
Key Findings & Data:Thirty five patients operated for PUV between 2006 and 2016 (mean 94 days, range 4 days12 years).
💡
Conclusion & Impact:Life long follow-up is obligate to protect from renal failure.
🔬Design:Research Article
📍Scope:2006 Verileri
⚙️Variables:Bladder disfunction · Posterior urethral valve · Renal function

Abstract

We aimed to evaluate the preoperative and postoperative renal and bladder functions of patients operated for posterior urethral valve (PUV). Thirty five patients operated for PUV between 2006 and 2016 (mean 94 days, range 4 days12 years). Seven patients had prenatal diagnosis. Preoperative and postoperative serum creatinine, Dimercaptosuccinic acid (DMSA), Voiding cystourethrography (VCUG), recurrent urinary tract infection, additional surgical procedures and urodynamic study results were evaluated. No vesicoureteral reflux (VUR) was demonstrated in four patients. No VCUG is obtained in two patients. Most of the bilateral VUR cases were grade IV or more. Thirteen patients had significant neuropathic bladder findings on VCUG and 21 had dilatation of posterior urethra. There were no preoperative DMSA scintigraphy in nine patients. Twenty two patients had a history of recurrent urinary tract infection. Nine of them had high grade reflux and seven of them had worsening of DMSA function with scars at postoperative follow-up. Preoperative/postoperative creatinine levels were 0.94mg/dL (0.14-4.63) / 0.39 mg/dL (0.11-2.3) respectivel. Five patients are on CIC (3 had Mitrofanoff conduit). Two patients underwent augmentation+Mitrofanoff and one patient had Mitrofanoff procedures. One underwent bilateral ureterostomy and one unilateral ureterostomy (undiversion at five years). Three received percutaneous vesicostomy procedure and one diverged to permanent vesicostomy. Seven has ESRD and two patients are on continous peritoneal dialysis. Postoperative UTI encountered in 22. Forty-two sessions of subureteric injection (17 right, 14 left, 11 bilateral) were performed. Urodynamic study conducted in 27 patients; 14 diagnosed as neuropathic bladder and 9 had DSD. Low bladder capacity and compliance was encountered in 17. Posterior urethral valve is the most important infravesical urinary obstruction that causes deterioration of renal function and permanent damage in boys in terms of long-term outcomes. Life long follow-up is obligate to protect from renal failure.

🔖

Cite This Article

BICAKCI, N., DEMİREL, B. D., BICAKCI, U., YAPICI, O. (2020). The long term renal and bladder function outcomes of patients with posterior urethral valve. Journal of Experimental and Clinical Medicine, Cilt: 37 - Sayı: 1, 11–16. https://ajindex.com/articles/678173

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Abdenanadher W, Chalouhi G, Dreux S., 2015. Fetal urine biochemistry at 13-23 weeks of getation in lower urinary tract obstruction: Criteria for in-utero treatment. Ultrasound Obstet Gynecol. 46(3): 306-311.
  2. Abraham MK, Nasir AR, Sudarsanan B, Puzhankara R, Kedari PM, Unnithan GR., 2009. Role of alpha adrenergic blocker in the management of posterior urethral valves. Pediatr Surg Int 25: 1113-1115.
  3. Berte N, Vrillon I, Larmure O, Gomola V, Ayav C, Mazeaud C, Lemelle JL., 2018 Long-term renal outcome in infants with congenital lower urinary tract obstruction. Prog Urol. Oct; 28 (12): 596-602.
  4. Bhadoo D, Bajpai M, Panda SS., 2014. Posterior urethral valve: Prognostic factors and renal outcome. J Indian Assoc Pediatr Surg. 19(3): 133-137.
  5. Bhatnagar V, Agarwala S, Lal r, Mitra DK., 2000. Fulguration of posterior urethral valves using the Nd: YAG laser. Pediatr Surg ınt. 16: 69-71.
  6. Bilgutay an, Roth DR, Gonzales ET, Janzen Nicolette, Zhang W, Koh cj, Gargollo P, Seth A., 2016. Posterior urethral valves: Risk factors for progression to renal failure. J Pediatr urol. 12: 179e1-179e7. Binghamn JB, Maisey MN., 1978. An evolution of the use of 99-Tc dimercaptosuccinic acid (DMSA) as a static renal imaging agent. Br J Urol. 51:599-602.
  7. Borzi PA, Beasley SW, Fpwler R., 1992. Posterior urethral valves in non twin siblings. Br J Urol. 70:201. Canning DA., 2019. Bladder contractility index in posterior urethral valves: A new marker early prediction of progression to renal failure. J Urol. May, 201(5): 846. Farnsworth RH, Rossleigh MA, Leighton DM, Bass SJ, Rosenberg AR., 1991. The detection of reflux nephropathy in infants by 99-Tc dimercaptosuccinic acid (DMSA) studies. J Urol. 145: 542-546.
  8. Fine ms, Smith KM, Shrivastava D, Cook ME, Shukla AR., 2011. Posterior urethral valve treatments and outcomes in children receiving kidney transplants. J Urol 185 (6 suppl): 2507-2511.
  9. Fumo MJ, Mclorie GA., 2006. Management of the valve-bladder syndrome and congenital bladder obstruction: the role of nocturnal bladder drainage. Nat Clin Pract Urol. 3: 323-326.
  10. Gordon I, Riccabona M., 2003. Investigation the newborn kidney: Update on imaging techniques. Semin Neonatal. 8:269-278.
  11. Hebenstreit D, Csaicich D, Hebenstreit k, Müller-Sacherer T, Berlakovich G, Springer A., 2018. Long-term outcome of pediatric renal transplantation in boys with posterior urethral valves. J Urol. Nov, 53(11): 2256-2260.
  12. Heikkila J, Holmberg C, Kyllonen L, Rintala R, Taskinen S., 2011. Long-term risk of end st